The triple combination of tumor PD-L1, intratumoral CD8+ cells and pretreatment B2M expression improved the prediction score over the single marker or dual combination of tumor PD-L1 and intratumoral CD8+ cell infiltration. This evidence concerns the gene CD274 and neoplasm.